Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.

Jens Dannull(University of St.Gallen), Marcus Groettrup(University of Konstanz), Ladislav Prikler, U Schmid, Thomas Cerny(University of Bern), Daniel Ackermann, G. Fürstenberger, P.A. Diener

PubMed

October 1, 2000

Cited by 144

Related Papers

A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis

|Nature Medicine|2009|594

Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group

|Journal of Clinical Oncology|2006|409

CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2

|Blood|2003|248

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

|British Journal of Cancer|1996|220

Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group

|Journal of Clinical Oncology|2011|190